Open access
Aug 2026
KRAS and SKIL mutations synergistically promote pancreatic tumorigenesis through the ubiquitin-proteasome-mediated degradation of Smad4
A novel synergy between SKIL loss and KRAS activation that drives pancreatic tumorigenesis through targeted Smad4 degradation is identified and aids in identifying high-risk populations for pancreatic cancer, specifically those harboring KRAS mutations.
Chen-Xi Wang, Ya-Rui Ma, Haixia Cheng et al.
· Journal of Experimental &... · 0 citations